Outset Medical

OM

Market cap $237M

Outset Medical, Inc. (NASDAQ:OM ) Morgan Stanley 23rd Annual Global Healthcare Conference September 10, 2025 7:00 AM EDT Company Participants Leslie Trigg - President, CEO & Chairman Renee Gaeta - CFO, Principal Financial Officer & Principal Accounting Officer Conference Call Participants Steven Trainor Presentation Steven Trainor Good morning, everyone. I'm Steven Trainor, Vice President with Morgan Stanley.

Outset Medical allegedly misled investors on Tablo's FDA status, sales risks, and growth prospects, lacking a reasonable basis for its positive outlook.

Collaboration to provide patients and caregivers access to innovative home dialysis with the Tablo® Hemodialysis System Collaboration to provide patients and caregivers access to innovative home dialysis with the Tablo® Hemodialysis System

SAN JOSE, Calif., Aug. 20, 2025 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced that management will present at the 23rd annual Morgan Stanley Global Healthcare Conference on Wednesday, Sept. 10, 2025, at 7 a.m. Eastern time.

Outset Medical (OM) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.

The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.

Outset Medical, Inc. (NASDAQ:OM ) Q2 2025 Earnings Conference Call August 6, 2025 5:00 PM ET Company Participants James S. Mazzola - Head of Investor Relations Leslie L.

Outset Medical, Inc. (OM) came out with a quarterly loss of $0.84 per share versus the Zacks Consensus Estimate of a loss of $1.76. This compares to a loss of $7.05 per share a year ago.

Company raises 2025 revenue guidance to a range of $122 million to $126 million Company raises 2025 revenue guidance to a range of $122 million to $126 million

SAN JOSE, Calif., July 30, 2025 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced Brittni McGill has been named to the newly created role of Chief Nursing Officer where she will apply her extensive nurse executive leadership experience to help increase strategic outreach and clinical program innovation designed to empower nurses and nurse leaders and elevate care.